Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
© 2026 Forbes Media LLC. All Rights Reserved.
Stop editing at 10% of Vim's power. Master registers, :norm, fuzzy completion, linematch diff, and 16 more Vim tricks. Tested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results